drugset / Trial / NCT02154776
Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.
NaSingle-groupOpen-labelOther
Summary
This is a multi-center, open-label, non-randomized, phase I study
Timeline
- Start
- 2014-06-27
- Primary completion
- 2016-10-26
- Completion
- 2016-10-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buparlisib | Small molecule | — | — |
| Subject | Letrozole | Other / unclassified | 2.5 mg | — |
| Subject | Ribociclib | Small molecule | — | — |